Japan’s Regenerative Cell Therapy Push Faces Crucial Review
A Japanese health ministry panel is set to review two regenerative therapies facing regulatory approval, a pivotal test of the country’s long-running push to build a domestic industry around advanced...
By Kanoko Matsuyama · Bloomberg
A Japanese health ministry panel is set to review two regenerative therapies facing regulatory approval, a pivotal test of the country’s long-running push to build a domestic industry around advanced cell-based treatments.